Basic dosimetry and radiobiology for radionuclide therapy
Basic dosimetry and radiobiology for radionuclide therapy

Basic Dosimetry and Radiobiology for Radionuclide Therapy - Applications closed

Explore the fundamentals of dosimetry and radiobiology for targeted radionuclide therapy and learn how to apply them in research and clinical practice. Guided by experts from the Dosimetry Core Unit, you will delve into the effective use of alpha- and beta-emitting radionuclides, gain insights into dose-effect relationships, and translate preclinical findings into clinical applications. This course provides an inspiring foundation for those looking to unlock the full potential of radionuclide therapy.

Would you like to stay informed about the Radboud Summer School 2026?
Sign up here to stay informed 

General

This course is sold out, registration is no longer possible.

Organized by the renowned Dosimetry Core Unit, this course offers a deep dive into the fundamentals of dosimetry and radiobiology, tailored for targeted radionuclide therapy. With expertise spanning the full translational pathway—from foundational research to clinical implementation—the course equips participants with the knowledge and skills needed to harness the full potential of alpha- and beta-emitting radionuclides in therapy.

Participants will gain a solid foundation in radiobiology, learning how radionuclide interactions affect biological systems, and will acquire practical skills in performing dosimetric calculations for both localized and systemic therapies. The course emphasizes bridging the gap between research and practice, focusing on identifying innovative applications of dosimetry and radiobiology, understanding dose-effect relationships, and translating preclinical parameters into actionable insights for clinical use.

Through a mix of expert-led lectures, interactive discussions, hands-on assignments, and guided tours, this program provides a stimulating and practical learning environment. Whether you are conducting research or working in clinical practice, this course will empower you to recognize new opportunities and optimize the use of dosimetry and radiobiology in radionuclide therapy.

Various teachers from the Dosimetry Core Unit will guide you through this Summerschool. There will be interactive lectures in the mornings and practicals/tours/demos in the afternoons. The global program is (Mon-Fri): introduction – radiobiology – dosimetry – advanced dosimetry – perspectives.

Learning objectives

  1. Perform basic dosimetric analyses for both localized and systemic radionuclide therapies.
  2. Understand the radiobiological mechanisms that underpin radionuclide therapy.
  3. Analyze dose-effect relationships in preclinical settings and translate findings into meaningful clinical applications.

Would you like to stay informed about this topic in the future?
Apply here to stay informed 

 

Starting date

23 June 2025, 8:30 am
Location
Buildings on campus
City
Nijmegen
Costs
€888
Discount
15% when applying before 1 April 2025
VAT-free
Yes
Educational method
On-site
Main Language
English
Deadline registration
15 May 2025, 11:59 pm
Maximum number of participants
32

Factsheet

Type of education
Summerschool
Entry requirements
A finished bachelor study in (bio)medical sciences, medical biology, medicine, chemistry, physics, or comparable.
Study load (ECTS)
2
Result
Certificate, Edubadge
Organisation
Radboudumc

Contact information

Radboud Summer School
Postbus 9102
6500 HC NIJMEGEN

radboudsummerschool [at] ru.nl (radboudsummerschool[at]ru[dot]nl)

Week 1:
 

Start date: Monday the 23rd of June 
 

End date: Friday the 27th of June

Summer School 2025 Timetable
Steffie Peters looking at camera

Dr. Steffie Peters received her MSc in Biomedical Engineering in 2011 at the Eindhoven University of Technology (NL), with a focus in medical imaging. She worked as a researcher at Philips Research (NL) for several years, after which she was trained as a Medical Physics Expert at the Radboud university medical center in Nijmegen (NL). She obtained her PhD in radionuclide dosimetry in 177Lu-PSMA therapy at the Radboud University (NL) in 2022. Combining her work as a Medical Physics Expert with her research experience, she has a strong focus on dosimetry in radionuclide therapy, covering in-depth knowledge on dosimetry physics as well as coordinating dosimetry protocols and requirements in daily clinical practice. She is coordinator of the Dosimetry Core Unit, and holds a position in several international committees and projects, including the EFOMP Special Interest Group for Internal Radionuclide Dosimetry, the SAMIRA Simplerad project by the European Commission, and the EANM EARL project group for 177Lutetium quantification. 

Mark Rijpkema looking at camera

Dr. Mark Rijpkema studied chemistry at the Radboud University of Nijmegen. After graduation he worked at the department of Radiology of the University Medical Center Nijmegen as PhD student in close collaboration with the department of Radiotherapy. He obtained his doctoral degree in 2003 with his thesis ‘MR imaging and MR spectroscopy to guide treatment selection for patients with tumours in the brain and head-neck region’. Subsequently, he worked as a postdoc at the University of Utrecht. In 2006, he moved back to Nijmegen to work at the Center for Cognitive Neuroscience of the Donders Institute, where he started a research line investigating the genetic underpinnings of brain structure and function, in close collaboration with the Human Genetics department. In 2011 he returned to the field of oncology at the department of Nuclear Medicine and started his own research group on intraoperative fluorescence imaging and image-guided surgery. A few years ago he specialized in supervising and teaching students. He now works as an assiocate professor at the department of Medical Imaging with a focus on teaching basic and advanced topics in molecular imaging. 

Jullie Nonnekens looking at camera

Dr. Julie Nonnekens received her MSc in Biotechnology at Wageningen University in 2009. She obtained her PhD in cancer biology with the focus on DNA repair mechanisms at the University of Toulouse (France) in 2013. Following, she was a postdoc at the Hubrecht Institute working on ribosome biogenesis in cancer and longevity. In 2014 Julie joined the Erasmus MC with a joint appointment as postdoc and is now Associate Professor at the Department of Molecular Genetics and Department of Radiology and Nuclear Medicine. Julie has received several (young investigator) awards and is principal investigator on various research grants including the prestigious ERC starting grant. She is chair of the Netherlands Society of Radiobiology and co-founder of the European working group on Radiobiology of Molecular Radionuclide Therapy.

Costs

Early bird | €754,80

The deadline for our early bird application is 31 March 2025.

Regular | €888

The deadline for our regular application is the 15 May 2025.

Includes

Your course, coffee and tea during breaks, warm lunch every day, welcome dinner on Monday, Official Opening, Official Closing.

Excludes

Transport, accommodation, social events and other costs. 

Discounts and scholarships

There are discounts and scholarships available for our partners. Click below to find out if you are eligible. 

Discounts and scholarships

Admission

Level of participant

Master, PHD, Postdoc, Professional.

Admission requirements

A finished bachelor study in (bio)medical sciences, medical biology, medicine, chemistry, physics, or comparable. 

Admission documents

Motivation letter and CV.